print-logo
Logo
  • Who we are Arrow Down
    • About us
    • Our purpose & values
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Lifecycle Management
    • Health Policy
    • Market Access
    • Medical Affairs
    • Marketing
    • Commercial Models
    • Customer & Market Insights
  • Insights Arrow Down
    • Publications
    • Project cases
  • Careers Arrow Down
    • Why join us
    • Open positions
    • Career paths
    • FAQ
  • Contact
  • |
  • Search Icon
  • Search
Back to What we do
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

Lifecycle Management

We support our clients in successfully positioning their products and creating value at all phases of the lifecycle: from development to launch, commercialization and beyond.

Pharma companies today need to have a laser focus on defining and delivering value to a diverse set of stakeholders, starting at discovery through to commercialization and end-of-exclusivity. The successful companies are the ones that put customers (payers, healthcare professionals, patients) at the heart of the value delivery process and deliver flawlessly across all functions across the whole lifecycle. Executive Insight supports leading biopharmaceutical companies in the key phases:

  • Shape value early on
    Integrating commercial and customer insights earlier into the new product process is key as a basis for early-stage decision making, for targeting promising compounds, and for increasing the potential to launch a successful drug. 
We support early-stage commercialization activities for example through therapeutic opportunity and competitive landscape assessments, through integrating the policy, payer, HCP and patient perspective and through strategic definition of value and positioning to guide the development process.
  • Maximize launch success
    A successful product launch in today’s competitive and regulated marketplace is highly dependent on value-based and science-driven decision making. Tightening constraints, especially on market access, are creating an increasingly tough launch environment. Success involves a thorough understanding what constitutes value for payers, HCPs and patients and finding a strong and relevant positioning to successfully differentiate and deliver on customer expectations.
We support clients in carving out clear a positioning, exploring and implementing beyond-the-pill strategies and shaping and communicating compelling value stories that resonate with payers, HCPs and patients. 
  • Boost brand and franchise performance
    In today’s highly competitive markets there is fierce competition, especially also from generics and biosimilars. To maximize the business opportunity in this stage there is a need to plan early, develop more comprehensive lifecycle management strategies and to continue to differentiate e.g. through product enhancements and services.
We support our clients in this phase for example through defining contracting strategies, a strategic approach to tender shaping or defining and implementing biosimilar defense strategies.

Contact our experts

Meike Wenzel

Meike Wenzel

Partner

mail_icon linkedin_icon
Marc Pesse

Marc Pesse

Partner

mail_icon linkedin_icon
Share this page
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Terms of use
  • Privacy policy
  • Imprint

2019 Executive Insight. All rights reserved.